Bob Nicholson

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Bristol-Myers Squibb (United States)14.3%
• United States Food and Drug Administration13.1%
• Pfizer (United States)12.7%
• GlaxoSmithKline (United States)9.4%
• Takeda (United States)7.8%
• Regeneron (United States)5.7%
• Other36.9%

Fields

• Immunology and Microbiology78.9%
• Chemistry5.3%
• Engineering5.3%
• Medicine5.3%
• Pharmacology, Toxicology and Pharmaceutics5.3%

Topics

• Biosimilars and Bioanalytical Methods30.2%
• Biosensors and Analytical Detection13.2%
• CAR-T cell therapy research9.4%
• Advanced Biosensing Techniques and Applications9.4%
• Innovative Microfluidic and Catalytic Techniques Innovation7.5%
• Cell Image Analysis Techniques7.5%
• Other22.6%